Showing 1 - 12 results of 12 for search 'Zhenya Hong', query time: 0.04s
Refine Results
-
1
-
2
Macrophage, the potential key mediator in CAR-T related CRS by Zhaonian Hao, Ruyuan Li, Li Meng, Zhiqiang Han, Zhenya Hong
Published 2020-07-01
Article -
3
Cervical cancer heterogeneity: a constant battle against viruses and drugs by Qian Sun, Liangliang Wang, Cong Zhang, Zhenya Hong, Zhiqiang Han
Published 2022-11-01
Article -
4
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends by Qian Sun, Zhenya Hong, Cong Zhang, Liangliang Wang, Zhiqiang Han, Ding Ma
Published 2023-08-01
Article -
5
-
6
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy by Zhaonian Hao, Ruyuan Li, Yuanyuan Wang, Shuangying Li, Zhenya Hong, Zhiqiang Han
Published 2021-10-01
Article -
7
TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic mod... by Zhenhao Wang, Yu Mei, Zhuming Yang, Qiang Gao, Hao Xu, Zhiqiang Han, Zhiqiang Han, Zhenya Hong
Published 2024-03-01
Article -
8
Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN by Jin Zhang, Jin Zhang, Kefeng Shen, Min Xiao, Jinjin Huang, Jin Wang, Yaqin Wang, Zhenya Hong
Published 2023-06-01
Article -
9
-
10
Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia by Hao Zhou, Wei Liu, Yongming Zhou, Zhenya Hong, Jian Ni, Xiaoping Zhang, Ziping Li, Mengyuan Li, Wenjuan He, Donghua Zhang, Xuexing Chen, Jianhua Zhu
Published 2021-11-01
Article -
11
The efficacy and safety of eltrombopag in treating TKI-induced thrombocytopenia in patients with chronic myeloid leukemia by Li Liu, Yilin Chen, Yan Liang, Li Meng, Jingming Guo, Chuancai Liu, Zhe Zhao, Jing Zou, Wenjuan He, Jiangzhao Zhang, Zhenya Hong, Caixia Liang, Xianjie Fu, Hui Wu, Youshan Zhang, Yanli Zhang, Weiming Li
Published 2023-12-01
Article -
12
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia by Chunrui Li, Wenyue Cao, Yimei Que, Qiuxiang Wang, Yi Xiao, Chaojiang Gu, Di Wang, Jue Wang, Lijun Jiang, Hao Xu, Jinhuan Xu, Xiaoxi Zhou, Zhenya Hong, Na Wang, Liang Huang, Shangkun Zhang, Liting Chen, Xia Mao, Min Xiao, Wei Zhang, Li Meng, Yang Cao, Tongcun Zhang, Jian Li, Jianfeng Zhou
Published 2021-03-01
Article